定量表观扩散系数测量及归一化表观扩散系数比值在诊断临床意义显著性外周带前列腺癌中的效用
回顾性分析95例外周带前列腺病灶(PI-RADSv2标准)并接受MRI-US融合活检的患者,两位放射科医师独立测量ADC值并以膀胱腔ROI计算归一化ADC比值。临床意义显著与非显著病灶的ADC分别为0.763×10⁻³ mm²/s与1.135×10⁻³ mm²/s(p<0.001),归一化ADC比值分别为29.8%与47.2%;ADC与ADC比值的AUC分别为0.880与0.885,观察者间ICC为0.889。
要点
- 临床意义显著外周带前列腺癌ADC均值为0.763×10⁻³ mm²/s,非显著者为1.135×10⁻³ mm²/s(p<0.001)。
- ADC诊断临床意义显著癌AUC 0.880,最佳阈值0.843×10⁻³ mm²/s(敏感度70.5%、特异度88.2%)。
- 归一化ADC比值AUC 0.885,最佳阈值33.1%(敏感度75.0%、特异度95.7%),观察者间ICC 0.889。
核心结论
- 外周带前列腺病灶的定量ADC测量在区分临床意义显著与非显著前列腺癌方面表现出优异的诊断性能,且观察者间相关性高。
研究设计与样本
- 回顾性分析经机构审查委员会批准,纳入95例外周带病灶(按PI-RADSv2标准)并接受后续MRI-US融合活检的患者;两位放射科医师独立测量病灶ROI的ADC值并以膀胱腔ROI计算归一化ADC比值,采用ROC评估诊断性能、ICC评估观察者间变异。
关键影像表现/征象
- 临床意义显著病灶的平均ADC为0.763×10⁻³ mm²/s,非临床意义显著病灶为1.135×10⁻³ mm²/s(p<0.001)。
- 临床意义显著病灶的归一化ADC比值为29.8%,非临床意义显著病灶为47.2%(p<0.001)。
诊断标准与关键数值
- ADC诊断临床意义显著外周带前列腺癌的AUC为0.880(95%CI 0.816-0.944),最佳阈值为0.843×10⁻³ mm²/s(敏感度70.5%、特异度88.2%)。
- 归一化ADC比值诊断临床意义显著外周带前列腺癌的AUC为0.885(95%CI 0.814-0.955),最佳阈值为33.1%(敏感度75.0%、特异度95.7%)。
- 观察者间组内相关系数(ICC)为0.889。
临床应用与阅片要点
- 定量ADC测量可作为多参数MRI评估前列腺病灶的附加方法,可能被纳入新的和现有的方法中以改善临床意义显著前列腺癌的检测与鉴别(原文结论)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study is to evaluate the utility of quantitative apparent diffusion coefficient (ADC) measurements and normalized ADC ratios in multiparametric MRI for the diagnosis of clinically significant peripheral zone (PZ) prostate cancer particularly among equivocally suspicious prostate lesions.
METHODS: A retrospective analysis of 95 patients with PZ lesions by PI-RADSv2 criteria, and who underwent subsequent MRI-US fusion biopsy, was approved by an institutional review board. Two radiologists independently measured ADC values in regions of interest (ROIs) of PZ lesions and calculated normalized ADC ratio based on ROIs in the bladder lumen. Diagnostic performance was evaluated using ROC. Inter observer variability was assessed using intraclass correlation coefficient (ICC).
RESULTS: Mean ADC and normalized ADC ratios for clinically significant and non-clinically significant lesions were 0.763 × 10-3 mm2 s-1, 29.8%; and 1.135 × 10-3 mm2 s-1, 47.2% (p < 0.001), respectively. Area under the ROC curve (AUC) was 0.880 [95% CI (0.816-0.944) and 0.885 (95% CI (0.814-0.955)] for ADC and ADC ratio, respectively. Optimal AUC threshold for ADC was 0.843 × 10-3 mm2 s-1 (Sn 70.5%, Sp 88.2%) and for normalized ADC was 33.1% (Sn 75.0%, Sp 95.7%). intraclass correlation coefficient was high at 0.889.
CONCLUSION: Quantitative ADC measurement in PZ prostate lesions demonstrates excellent diagnostic performance in differentiating clinically significant from non-clinically significant prostate cancer with high inter observer correlation. Advances In knowledge: Quantitative ADC is presented as an additional method to evaluate lesions in mpMRI of the prostate. This technique may be incorporated in new and existing methods to improve detection and discrimination of clinically significant prostate cancer.
引用
- Nguyen TB, Ushinsky A, Yang A, et al. Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer. Br J Radiol. 2018. PMID: 29869921. doi:10.1259/bjr.20180091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。